Literature DB >> 22497211

Differences in distribution and regulation of astrocytic aquaporin-4 in human and rat hydrocephalic brain.

A D Skjolding1, A V Holst1, H Broholm1, H Laursen1, M Juhler1.   

Abstract

AIMS: Aquaporin-4 (AQP4) is the most abundant cellular water channel in brain and could be a molecular basis for a cerebrospinal fluid absorption route additional to the arachnoid villi. In the search for 'alternative' cerebrospinal fluid absorption pathways it is important to compare experimental findings with human pathophysiology. This study compares expression of AQP4 in hydrocephalic human brain with human controls and hydrocephalic rat brain.
METHODS: Cortical biopsies from patients with chronic hydrocephalus (n = 29) were sampled secondary to planned surgical intervention. AQP4 in human hydrocephalic cortex relative to controls was quantified by Western blotting (n = 28). A second biopsy (n = 13) was processed for immunohistochemistry [glial fibrillary acidic protein (GFAP), CD68, CD34 and AQP4] and double immunofluorescence (AQP4 + GFAP and AQP4 + CD34). Brain tissue from human controls and kaolin-induced hydrocephalic rats was processed in parallel. Immunohistochemistry and immunofluorescence were assessed qualitatively.
RESULTS: Western blotting showed that AQP4 abundance was significantly increased (P < 0.05) in hydrocephalic human brain compared with controls. AQP4 immunoreactivity was present in both white and grey matter. In human brain (hydrocephalic and controls) AQP4 immunoreactivity was found on the entire astrocyte membrane, unlike hydrocephalic rat brain where pronounced endfeet polarization was present. Endothelial AQP4 immunoreactivity was not observed.
CONCLUSIONS: This study shows a significant increase in astrocytic AQP4 in human hydrocephalic cortex compared with control. Cell type specific expression in astrocytes is conserved between rat and human, although differences of expression in specific membrane domains are seen. This study addresses direct translational aspects from rat to human, hereby emphasizing the relevance and use of models in hydrocephalus research.
© 2012 The Authors. Neuropathology and Applied Neurobiology © 2012 British Neuropathological Society.

Entities:  

Keywords:  aquaporin; astrocytes; cerebrospinal fluid; endfeet; experimental; human; hydrocephalus; rat

Mesh:

Substances:

Year:  2013        PMID: 22497211     DOI: 10.1111/j.1365-2990.2012.01275.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  9 in total

1.  Glial and neuronal antibodies in patients with idiopathic intracranial hypertension.

Authors:  Güneş Altıokka-Uzun; Ece Erdağ; Betül Baykan; John Tzartos; Duygu Gezen-Ak; Bedia Samancı; Erdinç Dursun; Paraskevi Zisimopoulou; Katerina Karagiorgou; Christos Stergiou; Erdi Şahin; Esme Ekizoğlu; Murat Kürtüncü; Erdem Tüzün
Journal:  Neurol Sci       Date:  2017-07-21       Impact factor: 3.307

2.  Hydrocephalus in neuromyelitis optica.

Authors:  Stacey L Clardy; Claudia F Lucchinetti; Karl N Krecke; Vanda A Lennon; Orna O'Toole; Brian G Weinshenker; Clara D Boyd; Stephen Krieger; Corey McGraw; Yong Guo; Sean J Pittock
Journal:  Neurology       Date:  2014-04-23       Impact factor: 9.910

3.  Aquaporin-4 expression in the cerebrospinal fluid in congenital human hydrocephalus.

Authors:  Leandro Castañeyra-Ruiz; Ibrahim González-Marrero; Juan M González-Toledo; Agustin Castañeyra-Ruiz; Héctor de Paz-Carmona; Agustín Castañeyra-Perdomo; Emilia M Carmona-Calero
Journal:  Fluids Barriers CNS       Date:  2013-05-09

Review 4.  Structure and function of the ependymal barrier and diseases associated with ependyma disruption.

Authors:  Antonio J Jiménez; María-Dolores Domínguez-Pinos; María M Guerra; Pedro Fernández-Llebrez; José-Manuel Pérez-Fígares
Journal:  Tissue Barriers       Date:  2014-03-19

5.  Increased CSF aquaporin-4, and interleukin-6 levels in dogs with idiopathic communicating internal hydrocephalus and a decrease after ventriculo-peritoneal shunting.

Authors:  Martin J Schmidt; Christoph Rummel; Jessica Hauer; Malgorzata Kolecka; Nele Ondreka; Vanessa McClure; Joachim Roth
Journal:  Fluids Barriers CNS       Date:  2016-06-29

Review 6.  Blood-brain barrier and foetal-onset hydrocephalus, with a view on potential novel treatments beyond managing CSF flow.

Authors:  M Guerra; J L Blázquez; E M Rodríguez
Journal:  Fluids Barriers CNS       Date:  2017-07-13

7.  Megalencephalic leukoencephalopathy with cysts: the Glialcam-null mouse model.

Authors:  Marianna Bugiani; Mohit Dubey; Marjolein Breur; Nienke L Postma; Marien P Dekker; Timo Ter Braak; Ursula Boschert; Truus E M Abbink; Huibert D Mansvelder; Rogier Min; Jan R T van Weering; Marjo S van der Knaap
Journal:  Ann Clin Transl Neurol       Date:  2017-06-06       Impact factor: 4.511

Review 8.  Novel therapeutic modulators of astrocytes for hydrocephalus.

Authors:  Yijian Yang; Chuansen Wang; Rui Chen; Yuchang Wang; Changwu Tan; Jingping Liu; Qinghua Zhang; Gelei Xiao
Journal:  Front Mol Neurosci       Date:  2022-09-26       Impact factor: 6.261

Review 9.  The Neuroepithelium Disruption Could Generate Autoantibodies against AQP4 and Cause Neuromyelitis Optica and Hydrocephalus.

Authors:  Leandro Castañeyra-Ruiz; Ibrahim González-Marrero; Agustín Castañeyra-Ruiz; Juan M González-Toledo; María Castañeyra-Ruiz; Francisco J Perez-Molto; Emilia M Carmona-Calero; Agustín Castañeyra-Perdomo
Journal:  Int Sch Res Notices       Date:  2014-10-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.